Skip to content

LIDEFARMA: what changed

BE 0899.688.064NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€62,177
2024 · €25,890+€36,287
Equity
€315,147
2024 · €285,497+€29,650
Cash
€102,559
2024 · €85,077+€17,482
Balance sheet total
€495,027
2024 · €386,918+€108,109

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€44,853

    up €44,853 (+62.7%), from €71,539 to €116,392

    of which Furniture and vehicles: +€46,228

  • Cash +€17,482

    up €17,482 (+20.5%), from €85,077 to €102,559

    mainly Net result for the year (+€62,177) and Current portion of long-term debt (+€45,217)

  • Receivables within one year +€15,479

    up €15,479 (+21.0%), from €73,880 to €89,359

    of which Other amounts receivable: +€8,431

  • Current investments +€15,000

    up €15,000 (+22.7%), from €66,124 to €81,124

  • Stocks and contracts +€14,807

    up €14,807 (+16.6%), from €88,935 to €103,742

Equity and liabilities
  • Current portion of long-term debt +€45,217

    up €45,217 (+221%), from €20,442 to €65,659

  • Other debts +€32,527

    new in 2025: €32,527

  • Reserves +€29,650

    up €29,650 (+11.1%), from €266,897 to €296,547

  • Debts after one year -€12,761

    down €12,761 (-47.4%), from €26,940 to €14,179

  • Trade debts +€7,191

    up €7,191 (+17.1%), from €41,990 to €49,181

Income statement
  • Gross operating margin +€58,394

    up €58,394 (+66.0%), from €88,416 to €146,809

  • Financial charges +€12,193

    up €12,193 (+649%), from €1,879 to €14,072

  • Taxes +€11,226

    up €11,226 (+93.3%), from €12,028 to €23,254

  • Staff costs -€5,780

    down €5,780 (-21.0%), from €27,477 to €21,697

  • Depreciation +€3,459

    up €3,459 (+16.7%), from €20,709 to €24,167

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €25,890
Gross operating margin +€58,394
Staff costs +€5,780
Depreciation -€3,459
Other operating charges +€70
Financial income -€1,080
Financial charges -€12,193
Taxes -€11,226
Result 2025 €62,177
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€101,575
Investment -€84,021
Financing -€72
Cash 2024 €85,077
Net result for the year +€62,177
Depreciation +€24,167
Stocks and contracts -€14,807
Receivables within one year -€15,479
Deferred charges and accrued income -€486
Trade debts +€7,191
Tax, wage and social debts +€6,427
Other debts +€32,527
Accrued charges and deferred income -€142
Investment in fixed assets (net) -€69,021
Current investments -€15,000
Debts after one year -€12,761
Current portion of long-term debt +€45,217
Contributions, distributions and other -€32,527
Cash 2025 €102,559
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €386,918 €495,027 +€108,109 +27.9%
Fixed assets 21/28 €71,539 €116,392 +€44,853 +62.7%
Tangible fixed assets 22/27 €71,539 €116,392 +€44,853 +62.7%
Land and buildings 22 €711 €0 -€711 -100%
Plant, machinery and equipment 23 €1,276 €613 -€663 -52.0%
Furniture and vehicles 24 €69,551 €115,779 +€46,228 +66.5%
Current assets 29/58 €315,379 €378,634 +€63,255 +20.1%
Stocks and contracts in progress 3 €88,935 €103,742 +€14,807 +16.6%
Stocks 30/36 €88,935 €103,742 +€14,807 +16.6%
Amounts receivable within one year 40/41 €73,880 €89,359 +€15,479 +21.0%
Trade receivables 40 €55,946 €62,994 +€7,048 +12.6%
Other amounts receivable 41 €17,935 €26,365 +€8,431 +47.0%
Current investments 50/53 €66,124 €81,124 +€15,000 +22.7%
Cash at bank and in hand 54/58 €85,077 €102,559 +€17,482 +20.5%
Deferred charges and accrued income 490/1 €1,363 €1,849 +€486 +35.7%
Total equity and liabilities 10/49 €386,918 €495,027 +€108,109 +27.9%
Equity 10/15 €285,497 €315,147 +€29,650 +10.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €266,897 €296,547 +€29,650 +11.1%
Distributable reserves 133 €266,897 €296,547 +€29,650 +11.1%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €101,421 €179,880 +€78,459 +77.4%
Amounts payable after more than one year 17 €26,940 €14,179 -€12,761 -47.4%
Financial debts 170/4 €26,940 €14,179 -€12,761 -47.4%
Amounts payable within one year 42/48 €73,994 €165,356 +€91,362 +123%
Current portion of amounts payable after more than one year 42 €20,442 €65,659 +€45,217 +221%
Trade debts 44 €41,990 €49,181 +€7,191 +17.1%
Suppliers 440/4 €41,990 €49,181 +€7,191 +17.1%
Taxes, remuneration and social security 45 €11,562 €17,989 +€6,427 +55.6%
Taxes 450/3 €8,747 €15,222 +€6,475 +74.0%
Remuneration and social security 454/9 €2,816 €2,768 -€48 -1.7%
Other amounts payable 47/48 - €32,527 +€32,527
Accrued charges and deferred income 492/3 €486 €344 -€142 -29.2%
Remuneration, social security and pensions 62 €27,477 €21,697 -€5,780 -21.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €20,709 €24,167 +€3,459 +16.7%
Other operating charges 640/8 €1,512 €1,442 -€70 -4.6%
Gross operating margin 9900 €88,416 €146,809 +€58,394 +66.0%
Operating profit (loss) 9901 €38,718 €99,503 +€60,786 +157%
Financial income 75/76B €1,080 €0 -€1,080 -100%
Recurring financial income 75 €1,080 €0 -€1,080 -100%
Financial charges 65/66B €1,879 €14,072 +€12,193 +649%
Recurring financial charges 65 €1,879 €14,072 +€12,193 +649%
Profit (loss) for the period before taxes 9903 €37,918 €85,431 +€47,513 +125%
Income taxes 67/77 €12,028 €23,254 +€11,226 +93.3%
Profit (loss) for the period 9904 €25,890 €62,177 +€36,287 +140%
Profit (loss) for the period to be appropriated 9905 €25,890 €62,177 +€36,287 +140%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€317,298 to €381,188

Midpoint €343,919 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €315,147
Capitalised earnings €319,450 to €447,230
Indication €317,298 to €381,188

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€315,147
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€315,147

Capitalised earnings

net result for the year (9904)
2025
€62,177
2024
€25,890
2023
€46,102
2022
€56,133
2021
€35,885
Average result
€44,723
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€319,450 / €372,692 / €447,230

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.